To understand whether CD8 T cells infiltrating the tumor upon MMC treatment have the capacity to recognize and kill cancer cells, the activation and exhaustion status of those cells was assessed by studying the expression of the cytotoxic cell granule protein granzyme B and the exhaustion markers PD-1 and CTLA-4. The gene discussed is CTLA4; the disease is neoplasm.